In this same context, a prospective study, including 43 MM patients, BRAF, NRAS and KIT mutations in ctDNA and basal concentration were analyzed using ddPCR and correlated with basal and changes in tumor burden and OS (p < 0.05) [120]. The gene discussed is BRAF; the disease is neoplasm.